Rare diseases
Investigational molecules
Locations
Back to Germany1 286 clinical trials in Aachen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Guselkumab and Etanercept for Treating Chronic Plaque Psoriasis in Children Aged 6 to 17 Years
GermanyStudy on Apalutamide and Hormone Therapy Before Surgery for Patients with Advanced High-Risk Prostate Cancer
GermanyStudy on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment
BelgiumStudy Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer
GermanyStudy on Sibeprenlimab for Patients with IgA Nephropathy
GermanyStudy on the Effects of EDG-5506 for Adults and Adolescents with Becker Muscular Dystrophy
GermanyStudy on Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Low-Risk Multiple Myeloma
GermanyStudy on the Safety and Effectiveness of BCN-CP01 for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
BelgiumStudy on the Effect of Empagliflozin, Acetylcholine Chloride, Insulin Aspart, and Sodium Nitroprusside Dihydrate on Heart Failure with Preserved Ejection Fraction Patients
The NetherlandsStudy on Upadacitinib for Adults with Active Axial Spondyloarthritis
GermanyStudy on Atezolizumab for Patients with High-Risk Diffuse Large B-Cell Lymphoma
BelgiumStudy of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma treatments and various forms of breast cancer therapies, including studies of novel immunotherapy combinations for head and neck cancers.
Advanced therapeutic approaches including targeted treatments and combination therapies are being evaluated for improved patient outcomes.
Research targeting heart failure prevention and management of cardiovascular complications, with emphasis on innovative drug combinations and preventive treatments.
Studies focus on reducing cardiovascular events and improving long-term patient outcomes.
Clinical investigations addressing various chronic conditions, including inflammatory diseases and dermatological disorders.
Evaluating new therapeutic approaches for managing long-term conditions and improving quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
